Client: INTERMUNE

Content for an orphan disease

For INTERMUNE, we created the complete content for patients and professionals for the new web presence of the Orphan Drug Esbriet® - the first drug for the treatment of the rare disease idiopathic pulmonary fibrosis.

Effect:

For the first time, patients and professionals can get online information about the only treatment option available for this serious disease.